-
$150 – $210Price range: $150 through $210
Retatrutide (20mg / 30mg) is the world’s first triple-hormone receptor agonist (GLP-1, GIP, and Glucagon) engineered for advanced metabolic research. Representing the next generation of incretin therapy, it is investigated for its unparalleled ability to stimulate fat oxidation, increase energy expenditure, and provide the most aggressive weight loss outcomes in modern science. STRICTLY NOT FOR HUMAN CONSUMPTION.
-
$199 Original price was: $199.$125Current price is: $125.
Semaglutide 5mg is a potent, long-acting GLP-1 receptor agonist engineered for advanced research into metabolic health, appetite regulation, and glycemic control. Investigated for its unprecedented weight loss outcomes and cardiovascular benefits, it is the premier subject for studying the synchronization of the gut-brain axis. STRICTLY NOT FOR HUMAN CONSUMPTION.
-
$165 – $220Price range: $165 through $220
Tirzepatide is a groundbreaking dual-action metabolic peptide that targets both GLP-1 and GIP receptors. This “second-generation” incretin therapy is being intensely studied for its ability to produce superior weight loss and glycemic control compared to single-receptor agonists. Available in 30mg and 60mg high-purity lyophilized vials for precise laboratory calibration. STRICTLY NOT FOR HUMAN CONSUMPTION.
End of content
End of content